VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
VRTXVertex Pharmaceuticals Incorporated
$451.63$114.9B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksVRTXDividend History

VRTX logoVertex Pharmaceuticals Incorporated (VRTX) Dividend History

Income profile from 1991 to 2025 with payout safety and yield-on-cost trend

Trailing Dividend / Share
$0.00
0 payments in last 12 months
Dividend Yield
N/A
Current annualized yield
Payout Ratio
N/A
Unknown
Dividend Streak
0 years
Consecutive annual increases
5Y Dividend CAGRN/A
Current Yield on CostN/A
Yield on Cost Trendunknown

VRTX Dividend Income Check

Safety

Payout ratio data not available yet.

Consistency

0 straight years of dividend increases.

Income Trend

Yield on cost trend needs more history.

VRTX Dividend Scorecard

Yield & Income

Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0

Payout Safety

Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score4/9

Growth

Growth Streak0 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown

Total Returns

Buyback Yield1.8%
Total Shareholder Yield1.8%
1Y Total Return0.7%
5Y Total Return140.4%
Estimated $10K growth (return + dividends):
5Y ago$24,04210Y ago$52,07920Y ago$145,406

Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.

VRTX Dividend History

No dividend payment history available

This company has not paid dividends during the available data period.

Get VRTX's next ex-dividend date and payout in your inbox

Monthly dividend calendar — upcoming ex-dates for stocks you follow.

Free. Unsubscribe any time.

Dividend Analysis

Payout Safety

Vertex Pharmaceuticals Incorporated has limited earnings payout data (Unknown).

Piotroski F-Score: 4/9 — moderate financial health.

Growth Track Record

VRTX does not have a current streak of consecutive dividend increases.

Total Shareholder Returns

Beyond cash dividends, VRTX returns capital through share repurchases. The combined picture: 1.8% buyback yield, 1.8% total shareholder yield.

Income Trend & Total Return

The 5-year total return is 140.4%.

DRIP Growth

A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $52,079 today.

VRTX Dividend vs Peers

Comparable companies in the same industry

Div Yield
—
—
Safety
Unknown
— payout
Streak
0Y
— 5Y CAGR
Total Shareholder
1.8%
#3 of 3
CompanyMkt CapYieldPayoutFCF PayoutStreak5Y GrowthBuybackTSY1Y ReturnSafety
VRTX logoVRTXVertex Pharmaceutica…
$114.9B———0—1.8%1.8%0.7%Unknown
2nd
REGN logoREGNRegeneron Pharmaceut…
$63.4B0.6%8.2%8.7%1—6.3%6.8%19.5%Sustainable
1st
ABBV logoABBVAbbVie Inc.
$383.2B3.0%2.8%65.2%436.8%0.3%3.3%20.4%Sustainable

VRTX Annual Dividend History (1991–2025)

35 years of dividend data

GrowthDecline
YearDPSYoYPmtsEPSPayoutCoverageFCF/ShareFCF PayoutBuyback YldTotal Shld YldYOC
2025$0.00—0$15.32——$12.38—1.7%1.7%—
2024$0.00—0$-2.08——$-3.06—1.1%1.1%—
2023$0.00—0$13.89——$12.59—0.4%0.4%—
2022$0.00—0$12.82——$15.15—0.0%0.0%—
2021$0.00—0$9.01——$9.27—2.5%2.5%—
2020$0.00—0$10.29——$11.37—0.9%0.9%—
2019$0.00—0$4.51——$5.73—0.3%0.3%—
2018$0.00—0$8.09——$4.53—0.8%0.8%—
2017$0.00—0$1.04——$2.31—0.0%0.0%—
2016$0.00—0$-0.46——$0.73—0.0%0.0%—
Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into VRTX consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

35+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

VRTX — Frequently Asked Questions

Quick answers to the most common questions about buying VRTX stock.

How much dividend does VRTX pay per share?

Vertex Pharmaceuticals Incorporated (VRTX) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.

When is VRTX's next ex-dividend date?

VRTX's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. VRTX typically pays dividends quarterly.

Is VRTX's dividend safe?

VRTX's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.

How many years has VRTX increased its dividend?

VRTX has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.

How often does VRTX pay dividends?

Vertex Pharmaceuticals Incorporated pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 34+ years from 1991 to 2025.

How much would $10,000 invested in VRTX grow with dividend reinvestment?

With dividends reinvested (DRIP), $10,000 invested in VRTX five years ago would be worth approximately $24,042 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.

What is VRTX's yield on cost for long-term holders?

VRTX's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.